Science • Medicine

BioNTech-Pfizer to start pediatric Covid-19 vaccine trial

BioNTech-Pfizer to start pediatric Covid-19 vaccine trial
Credit: Illustration: Pendect, Ashley Winkler (Creative Commons Attribution ShareAlike 4.0)

BioNTech and Pfizer announced Thursday that they are launching pediatric trials of their Covid-19 vaccine on children 12 years and under.

"Together with our partner BioNTech, we have announced a global study to further evaluate our #COVID19 vaccine in healthy children ages 6 months to 11 years. We are proud to start this much needed study for children and families eagerly awaiting a possible vaccine option," Albert Bourla,

Chairman and CEO of Pfizer, announced on Twitter. "As a father and a scientist, I would like to thank our participants and their parents and caregivers for enrolling in the study. We need to continue gathering evidence on the safety and efficacy of #COVID19 vaccines for important populations, including children."

Highly edible human, designer of all things digital, co-founder of Pendect, creative native, constant wa/onderer, morse code lady, full-time dog pillow.
Card reviewed by: @christoph